These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13678942)

  • 1. Retrograde coronary perfusion: a superior route to deliver therapeutics to the heart?*.
    Giordano FJ
    J Am Coll Cardiol; 2003 Sep; 42(6):1129-31. PubMed ID: 13678942
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective pressure-regulated retroinfusion of fibroblast growth factor-2 into the coronary vein enhances regional myocardial blood flow and function in pigs with chronic myocardial ischemia.
    von Degenfeld G; Raake P; Kupatt C; Lebherz C; Hinkel R; Gildehaus FJ; Münzing W; Kranz A; Waltenberger J; Simoes M; Schwaiger M; Thein E; Boekstegers P
    J Am Coll Cardiol; 2003 Sep; 42(6):1120-8. PubMed ID: 13678941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant Retrograde Coronary Venous Infusion of Basic Fibroblast Growth Factor Enhances Engraftment and Differentiation of Bone Marrow Mesenchymal Stem Cells for Cardiac Repair after Myocardial Infarction.
    Wang X; Zhen L; Miao H; Sun Q; Yang Y; Que B; Lopes Lao EP; Wu X; Ren H; Shi S; Lau WB; Ma X; Ma C; Nie S
    Theranostics; 2015; 5(9):995-1006. PubMed ID: 26155315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracoronary basic fibroblast growth factor enhances myocardial collateral perfusion in dogs.
    Rajanayagam MA; Shou M; Thirumurti V; Lazarous DF; Quyyumi AA; Goncalves L; Stiber J; Epstein SE; Unger EF
    J Am Coll Cardiol; 2000 Feb; 35(2):519-26. PubMed ID: 10676703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure.
    Banquet S; Gomez E; Nicol L; Edwards-Lévy F; Henry JP; Cao R; Schapman D; Dautreaux B; Lallemand F; Bauer F; Cao Y; Thuillez C; Mulder P; Richard V; Brakenhielm E
    Circulation; 2011 Aug; 124(9):1059-69. PubMed ID: 21824923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficiency of drug delivery to the coronary arteries in swine is dependent on the route of administration: assessment of luminal, intimal, and adventitial coronary artery and venous delivery methods.
    Karanian JW; Peregoy JA; Chiesa OA; Murray TL; Ahn C; Pritchard WF
    J Vasc Interv Radiol; 2010 Oct; 21(10):1555-64. PubMed ID: 20813544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic myocardial angiogenesis using percutaneous intrapericardial drug delivery.
    Laham RJ; Hung D; Simons M
    Clin Cardiol; 1999 Jan; 22(1 Suppl 1):I6-9. PubMed ID: 9929761
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The delivery of angiogenic factors to the heart by microsphere therapy.
    Arras M; Mollnau H; Strasser R; Wenz R; Ito WD; Schaper J; Schaper W
    Nat Biotechnol; 1998 Feb; 16(2):159-62. PubMed ID: 9487522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardioplegia by way of the coronary sinus for valvular and coronary surgery.
    Menasche P; Piwnica A
    J Am Coll Cardiol; 1991 Aug; 18(2):628-36. PubMed ID: 1856432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of high-pressure retrograde coronary venous delivery of FGF-2 protein.
    Fearon WF; Ikeno F; Bailey LR; Hiatt BL; Herity NA; Carter AJ; Fitzgerald PJ; Rezaee M; Yeung AC; Yock PG
    Catheter Cardiovasc Interv; 2004 Mar; 61(3):422-8. PubMed ID: 14988909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of angiogenesis via topical delivery of basic-fibroblast growth factor from polyvinyl alcohol-dextran blend hydrogel in an ovine model of acute myocardial infarction.
    Fathi E; Nassiri SM; Atyabi N; Ahmadi SH; Imani M; Farahzadi R; Rabbani S; Akhlaghpour S; Sahebjam M; Taheri M
    J Tissue Eng Regen Med; 2013 Sep; 7(9):697-707. PubMed ID: 22674791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beauty in simplicity.
    Peters R; Sikorski R
    Science; 1998 Apr; 280(5362):456-7. PubMed ID: 9575088
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results.
    Sellke FW; Laham RJ; Edelman ER; Pearlman JD; Simons M
    Ann Thorac Surg; 1998 Jun; 65(6):1540-4. PubMed ID: 9647055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracoronary and intravenous administration of basic fibroblast growth factor: myocardial and tissue distribution.
    Laham RJ; Rezaee M; Post M; Sellke FW; Braeckman RA; Hung D; Simons M
    Drug Metab Dispos; 1999 Jul; 27(7):821-6. PubMed ID: 10383927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution.
    Lazarous DF; Shou M; Stiber JA; Dadhania DM; Thirumurti V; Hodge E; Unger EF
    Cardiovasc Res; 1997 Oct; 36(1):78-85. PubMed ID: 9415275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on myocardial perfusion of simultaneous delivery of cardioplegic solution through a single coronary artery and the coronary sinus.
    Tian G; Dai G; Xiang B; Sun J; Lindsay WG; Deslauriers R
    J Thorac Cardiovasc Surg; 2001 Nov; 122(5):1004-10. PubMed ID: 11689807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myocardial distribution of retrograde cardioplegic solution assessed by myocardial thallium 201 uptake.
    Carrier M; Grégoire J; Khalil A; Thai P; Latour JG; Pelletier LC
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1115-8. PubMed ID: 7983880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transendocardial and transepicardial intramyocardial fibroblast growth factor-2 administration: myocardial and tissue distribution.
    Laham RJ; Post M; Rezaee M; Donnell-Fink L; Wykrzykowska JJ; Lee SU; Baim DS; Sellke FW
    Drug Metab Dispos; 2005 Aug; 33(8):1101-7. PubMed ID: 15879496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor.
    Yanagisawa-Miwa A; Uchida Y; Nakamura F; Tomaru T; Kido H; Kamijo T; Sugimoto T; Kaji K; Utsuyama M; Kurashima C
    Science; 1992 Sep; 257(5075):1401-3. PubMed ID: 1382313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial.
    Laham RJ; Sellke FW; Edelman ER; Pearlman JD; Ware JA; Brown DL; Gold JP; Simons M
    Circulation; 1999 Nov; 100(18):1865-71. PubMed ID: 10545430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.